Application of serum thymidine kinase 1 of 26 055 cases in health screening for early detection of premalignant/early malignant tumors / 中南大学学报(医学版)
Journal of Central South University(Medical Sciences)
;
(12): 1029-1034, 2014.
Artigo
em Chinês
| WPRIM
| ID: wpr-815488
ABSTRACT
OBJECTIVE@#To determine the application of serum thymidine kinase 1 (STK1) in general health screening for early detection of premalignant/early malignant tumors.@*METHODS@#A cross sectional study was carried out in 26 055 health screenings from 8 centers of Changsha in 2011. The concentration of STK1 was determined by a sensitive chemiluminescent dot blot ECL assay.@*RESULTS@#In the elevated STK1 group 60.35% showed diseases with a higher risk of premalignant/ early cancerous progression. The positive rate of elevated STK1 (>2.0 pmol/L) was 2.61%. There was a significantly higher rate with moderate/severe type of hyperplasia of breasts and prostate with elevated STK1 than people with normal STK1 values.@*CONCLUSION@#STK1 may be a reliable marker for risk assessment of premalignant/early malignant tumors.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Patologia
/
Lesões Pré-Cancerosas
/
Próstata
/
Timidina Quinase
/
Sangue
/
Mama
/
Biomarcadores Tumorais
/
Estudos Transversais
/
Diagnóstico
/
Detecção Precoce de Câncer
Tipo de estudo:
Estudo diagnóstico
/
Estudo observacional
/
Estudo de prevalência
/
Fatores de risco
/
Estudo de rastreamento
Limite:
Feminino
/
Humanos
/
Masculino
Idioma:
Chinês
Revista:
Journal of Central South University(Medical Sciences)
Ano de publicação:
2014
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS